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Introduction
Fibroblasts synthesize, organize, and maintain connective tis-
sues during development and in response to injury and fi  brotic 
disease (Trinkaus, 1984; Tomasek et al., 2002; Desmouliere 
et al., 2004). Cells cultured in three-dimensional (3D) collagen 
matrices have been used to study fi  broblast–matrix interactions 
in a tissue-like environment. Fibroblast morphology in the 3D 
environment ranges from dendritic to stellate to bipolar, de-
pending on matrix stiffness and tension (Cukierman et al., 2002; 
Grinnell, 2003), which is similar to cells in tissues (Goldsmith 
et al., 2004; Langevin et al., 2005) and quite distinct from the 
fl  attened morphology of fi  broblasts on two-dimensional (2D) 
tissue culture surfaces.
Cells can exert mechanical force on their surroundings 
(Bershadsky et al., 2003; Ingber, 2003; Katsumi et al., 2004; 
Meshel et al., 2005), and fi  broblasts in 3D collagen matrices use 
this force to contract the matrix (Brown et al., 1998; Tomasek 
et al., 2002; Grinnell, 2003; Petroll and Ma, 2003; Vanni et al., 
2003; Wakatsuki and Elson, 2003). The mechanism by which 
fi  broblasts regulate the contraction of 3D collagen matrices has 
been shown to vary according to growth factor stimulus, me-
chanical environment, and the differentiation state of the cells. 
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The physiological agonists PDGF and lysophosphatidic acid 
(LPA) both stimulate fl  oating matrix contraction, even though 
these agonists have opposite effects on the movement of cellular 
dendritic extensions within the matrices. PDGF increases their 
protrusion; LPA causes their retraction (Grinnell et al., 2003).
Studies with C3 exotransferase showed that the small 
G protein Rho is required for fl  oating matrix contraction by 
  either PDGF or LPA (Grinnell et al., 1999), but only PDGF-
stimulated, and not LPA-stimulated, contraction was inhibited 
by blocking the Rho effector Rho kinase (Abe et al., 2003; Lee 
et al., 2003). Therefore, PDGF and LPA regulate fl  oating colla-
gen matrix contraction, in part, by different signaling mecha-
nisms, and it has remained an open question as to whether there 
is a point of convergence.
p21-activated kinases (PAKs) were fi  rst identifi  ed as Rac- 
and Cdc42-interacting proteins (Manser et al., 1994) and are 
now known to be important in the regulation of cytoskeletal 
  organization and cell migration (Bokoch, 2003; Zhao and 
 Manser, 2005). Early on, PAK1 was recognized as a  downstream 
effector for PDGF (Bokoch et al., 1996; Dharmawardhane 
et al., 1997), but more recently was shown to also be important 
for LPA-mediated signaling (Menard and Mattingly, 2003; 
Jung et al., 2004). In this study, we show that the PDGF and 
LPA signaling pathways that regulate matrix contraction con-
verge on PAK1 and its downstream effector cofi  lin and that 
contraction depends on cellular ruffl  ing activity, rather than on 
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F
ibroblast three-dimensional collagen matrix culture 
provides a tissue-like model that can be used to 
analyze cell form and function. The physiological 
  agonists platelet-derived growth factor (PDGF) and lyso-
phosphatidic acid (LPA) both stimulate human ﬁ  broblasts 
to contract ﬂ  oating collagen matrices. In this study, we 
show that the PDGF and LPA signaling pathways re-
quired for matrix contraction converge on p21-activated 
kinase 1 (PAK1) and its downstream effector coﬁ  lin1 and 
that contraction depends on cellular rufﬂ   ing activity, 
rather than on the protrusion and retraction of cellular 
dendritic extensions. We also show that, depending on 
the agonist, different Rho effectors cooperate with PAK1 
to regulate matrix contraction, Rho kinase in the case of 
PDGF and mDia1 in the case of LPA. These ﬁ  ndings es-
tablish a uniﬁ  ed framework for understanding the cell 
signaling pathways involved in ﬁ  broblast contraction of 
ﬂ  oating collagen matrices.T
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Figure 1.  PAK1 silencing in human ﬁ   broblasts and cell morphology. 
(A) Cells were transfected for 12 h with 700 nM siRNA or sense RNA only 
(Mock) and cultured for an additional 24 h in growth medium without 
siRNA. Extracts were prepared and subjected to SDS-PAGE and immuno-
blotted to analyze levels of PAK1, PAK2, and tubulin. (B) PAK1-silenced 
and mock-transfected cells were harvested and incubated for 1 h on 
collagencoated glass coverslips in DME containing 5 mg/ml BSA and 10 μM 
LPA or 50 ng/ml PDGF as indicated. At the end of the incubation, samples 
were ﬁ  xed and stained for actin. Bar, 50 μm.
Figure 2.  Silencing PAK1 inhibits cell migration. (A) PAK1-silenced and 
mock-transfected cells were harvested and cultured overnight on collagen-
coated coverslips. After scrape wounding, the cultures were incubated in 
DME containing 5 mg/ml BSA and 50 ng/ml PDGF. At the end of the incu-
bations, samples were ﬁ  xed and stained for actin. (B) Migration was quan-
tiﬁ  ed by determining the average distance of cell migration from the wound 
edge based on measurement of 10 separate microscopic ﬁ  elds and 5 cells 
within each ﬁ  eld. Bar, 150 μm.T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
PAK1 AND COLLAGEN MATRIX CONTRACTION • RHEE AND GRINNELL 425
protrusion and retraction of cellular dendritic extensions. We 
also show that, depending on the agonist, different Rho effec-
tors are required to cooperate with PAK1 to regulate matrix 
contraction, Rho kinase in the case of PDGF and mDia1 in the 
case of LPA.
Results
Effects of PAK1 silencing on ﬁ  broblast 
morphology and of migration 
on collagen-coated coverslips
We used small interfering RNA (siRNA) to knock down PAK1 
expression in human fibroblasts. Fig. 1 A shows an example 
of immunoblot analysis performed on cell lysates prepared from 
cells after a 36-h transfection with PAK1-specifi  c  double-
stranded siRNA. Levels of PAK1 in the PAK1 siRNA, but not 
in mock-transfected cells, were reduced by almost 95% without 
affecting levels of PAK2.
Fig. 1 B shows the morphology of PAK1-silenced versus 
mock-transfected cells by fl  uorescence visualization of actin. 
Compared with control cells, knocking down PAK1 had no de-
tectable effect on cell spreading or response to PDGF and LPA 
in 2D culture. Treatment with PDGF caused the appearance of 
small lamellipodia along the cell margins, and treatment with 
LPA increased formation of actin stress fi  bers.
Transfection studies with modifi  ed PAK1 constructs have 
demonstrated a role for PAK1 in cell motility (Sells et al., 
1999). Consistent with this fi  nding, human fi  broblast migration 
was decreased by knocking down PAK1. Fig. 2 A shows the 
typical appearance of cultures that were scrape wounded and 
incubated in medium containing PDGF. During the initial 3–6 h 
of culture, both mock-transfected and PAK1 knockdown cells 
extended lamellipodia into the scrape region. By 24 h of incuba-
tion, however, PAK1 knockdown cells had migrated substan-
tially further into the wound region compared with the controls. 
Fig. 2 B shows the results quantitatively with the difference in 
cell migration evident by 12 h.
PAK1 silencing inhibits cell rufﬂ  ing 
and matrix contraction by ﬁ  broblasts 
in 3D collagen matrices
Fibroblasts within 3D collagen matrices protrude a dendritic 
network of extensions that expands in response to PDGF 
stimulation and retracts in response to LPA stimulation (Abe 
et al., 2003). Fig. 3 (1 h) and Fig. 4 (4 h) show representative 
photomicrographs of the network under basal (BSA), expanded 
(PDGF), and retracted (LPA) conditions. Fibroblast dendritic 
extensions have microtubule cores (Figs. 3 and 4, green) with 
ruffl  ing, actin-rich tips (red). Retraction of the extensions in 
response to LPA stimulation occurred within 1 h in PAK1-silenced 
Figure 3.  Dendritic extensions and rufﬂ   ing by PAK1-
  silenced human ﬁ  broblasts incubated for 1 h in collagen 
matrices.  (A) PAK1-silenced and mock-transfected cells 
were harvested and used to prepare ﬂ  oating  collagen 
  matrices. Samples were incubated for 1 h in DME contain-
ing 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA, as 
indicated. At the end of the incubations, samples were 
ﬁ  xed and stained with anti-tubulin antibody for microtu-
bules and rhodamine-phalloidin for actin. (B) Enlarged 
view of dendritic extension tips in the boxed areas. Green, 
microtubules; red, actin. Bar, 20 μm.
Figure 4.  Dendritic extensions and rufﬂ   ing by PAK1-
  silenced ﬁ  broblasts incubated for 4 h in collagen matrices. 
(A) PAK1-silenced and mock-transfected cells were har-
vested and used to prepare ﬂ   oating collagen matrices. 
Samples were incubated for 4 h in DME containing 5 mg/ml 
BSA and 50 ng/ml PDGF or 10 μM LPA, as indicated. 
At the end of the incubations, samples were ﬁ  xed  and 
stained with anti-tubulin antibody for microtubules and 
rhodamine-phalloidin for actin. (B) Enlarged view of 
  dendritic extension tips in the boxed areas. Green, 
micro  tubules; red, actin. Bar, 20 μm.JCB • VOLUME 172 • NUMBER 3 • 2006  426
or mock-transfected cells, after which most fi  broblasts either 
were round or had short extensions. Expansion of the dendritic 
network in response to PDGF was reduced in PAK1 knockdown 
cells. Table I shows morphometric analysis of a representative 
experiment. After 4 h in basal- and PDGF-containing medium, 
the projected cell area, branch length, and number of branches 
were all lower in PAK1-silenced cells. Therefore, PAK1 played 
a role in regulation of fi   broblast dendritic extensions, but 
formation of the extensions was PAK1 independent.
The actin-rich tips of fi  broblast extensions (protruded or 
retracted) showed prominent ruffl  ing activity. In general, ruf-
fl  ing was more evident in PDGF- and LPA-stimulated cells 
than in basal (BSA) medium, and Figs. 3 B and 4 B show that 
cell ruffl  ing induced by PDGF or LPA was markedly reduced 
in PAK1-silenced cells, compared with mock-  transfected 
cells. Therefore, PAK1 appeared to be necessary for cell 
ruffl  ing, regardless of whether the cells were stimulated by 
PDGF or LPA.
Collagen matrix contraction experiments also were per-
formed using PAK1-silenced and mock-transfected cells. 
  Contraction was quantifi  ed by measuring the diameter of col-
lagen matrices before ( 12 mm) and after contraction and 
then calculating the difference. Fig. 5 shows that after 4 h in 
the presence of LPA or PDGF, contraction was  6–7 mm for 
control cells and  2 mm for PAK1 knockdown cells. The 
latter value is comparable to the level of basal contraction 
without agonist stimulation. These fi  ndings  demonstrated 
that PAK1 was required for both PDGF- and LPA-stimulated 
matrix contraction.
Inhibiting phosphoinositide 3 (PI3) kinase 
selectively blocks PDGF-stimulated collagen 
matrix contraction and cell rufﬂ  ing
Current studies suggested PAK1 as a potential point of conver-
gence in PDGF and LPA regulation of cell ruffl  ing and collagen 
matrix contraction. Activation of cell ruffl  ing and PAK in re-
sponse to PDGF stimulation depends on PI3 kinase  (Hooshmand-
Rad et al., 1997; Sells et al., 2000). In previous papers, the 
role of PI3 kinase in contraction of fl  oating collagen matrices 
was tested, but the fi  ndings were inconsistent (Ahlen et al., 
1998; Skuta et al., 1999; Han et al., 2002). In preliminary 
  experiments, we established that 20 μM LY294002 inhibited 
PDGF-stimulated PI3 kinase activity based on measurement of 
Akt phosphorylation (unpublished data). Fig. 6 A demonstrates 
that this concentration of the PI3 kinase inhibitor (LY) blocked 
PDGF-stimulated, but not LPA-stimulated, matrix contraction. 
In addition, Fig. 6 B shows that blocking PI3 kinase inhibited 
PDGF-stimulated, but not LPA-stimulated, cell ruffl  ing. There-
fore, PI3 kinase was required for both cell ruffl  ing and contrac-
tion stimulated by PDGF, whereas the link between LPA and 
PAK1 appeared to be PI3 kinase independent, as has been re-
ported (Menard and Mattingly, 2003).
Pertussis toxin treatment selectively 
blocks LPA-stimulated matrix contraction 
and cell rufﬂ  ing
LPA receptors couple to multiple G protein signaling pathways 
(Anliker and Chun, 2004; Moolenaar et al., 2004), and Gαi has 
been implicated in fl  oating collagen matrix contraction (Skuta 
et al., 1999). Fig. 7 A shows that overnight treatment with per-
tussis toxin inhibited LPA-stimulated, but not PDGF- stimulated, 
matrix contraction. In addition, Fig. 7 B shows that pertussis 
toxin treatment inhibited cell ruffl  ing stimulated by LPA. These 
fi  ndings provided evidence for a link between PAK1-dependent 
cell ruffl  ing and contraction stimulated by LPA, which was dis-
tinct from PDGF.
Downstream role of coﬁ  lin1 in PAK1-
dependent collagen matrix contraction
The actin dynamics required for fi  broblast ruffl  ing can be con-
trolled at the level of actin-depolymerizing factor (ADF)/cofi  lin 
by the PAK1 effector LIM kinase (Arber et al., 1998; Yang 
et al., 1998; Bamburg, 1999; Edwards et al., 1999). Fig. 8 A 
shows that with fi  broblasts in 3D collagen matrices, PDGF and 
LPA stimulated cofi  lin1 phosphorylation and that stimulation 
was inhibited in PAK1-silenced cells. Contraction experiments 
were performed after knocking down cofi  lin1 using siRNA, 
which, as shown in Fig. 8 B, could be reduced by >70%. Fig. 
8 C demonstrates that in cofi  lin1-silenced cells, collagen ma-
trix contraction was inhibited. Also, cells ceased their ruffl  ing 
Table I. Morphometric analysis of cell extensions in 3D collagen matrices
Cell 
sample
Growth factor Projected 
cell area
Branch 
length
Number 
of branches
μm
2 μm
Mock none 1,583 ± 422 57 ± 20 9.8 ± 3.3
siRNA none    941 ± 359 45 ± 19 6.3 ± 2.5
P value 0.048 0.043 0.14
Mock PDGF 2,547 ± 773 74 ± 23 12.7 ± 3.4
siRNA PDGF 1,006 ± 279 44 ± 15 8.0 ± 2.5
P value 0.003 0.0003 0.03
PAK1-silenced and mock-transfected cells were harvested and used to prepare 
ﬂ  oating collagen matrices. Samples were incubated for 4 h in DME containing 
5 mg/ml BSA and 50 ng/ml PDGF, as indicated. At the end of the incuba-
tions, samples were ﬁ  xed and stained with rhodamine-phalloidin for actin. For 
each value, measurements were made on 50 cells that were photographed 
at random.
Figure 5.  Inhibition of collagen matrix contraction in PAK1-silenced cells. 
Nontransfected (Control), PAK1-silenced, and mock-transfected cells were 
harvested and used to prepare ﬂ  oating collagen matrices. Samples were 
incubated for 4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF or 
10 μM LPA added as shown. At the end of the incubations samples 
were ﬁ   xed and the extent of matrix contraction was measured as the 
  decrease in matrix   diameter. Data shown are arithmetic mean ± SD for 
three separate experiments.PAK1 AND COLLAGEN MATRIX CONTRACTION • RHEE AND GRINNELL 427
  activity (unpublished data). Therefore, it could be concluded 
that cofi  lin1 was a downstream effector for PAK1 in LPA- and 
PDGF-stimulated collagen matrix contraction.
Different Rho effectors cooperate 
with PAK1 to regulate LPA- and 
PDGF-stimulated matrix contraction 
Together, the experiments identifi  ed PAK1 as a downstream 
convergence point for the regulation of both cell ruffl  ing and 
collagen matrix contraction stimulated by PDGF and LPA. 
As already mentioned, PDGF- and LPA-dependent fl  oating col-
lagen matrix contraction requires activity of the small G protein 
Rho (Grinnell et al., 1999), but only PDGF-stimulated contrac-
tion was dependent on the Rho effector Rho kinase (Abe et al., 
2003; Lee et al., 2003). Consistent with this observation, Fig. 
6 A shows that blocking Rho kinase (Y) inhibited PDGF-
  dependent, but not LPA-dependent, contraction of fl  oating 
  collagen matrices. Moreover, blocking Rho kinase did not 
cause a decrease in cell ruffl  ing (unpublished data). Therefore, 
rather than functioning in the same signaling pathway as 
PAK1, it seemed likely that PAK1 and Rho acted in parallel 
 cooperative  fashion.
Along with Rho kinase, mDia1 has been implicated as a 
Rho effector for regulation of actin cytoskeletal dynamics and 
force generation (Watanabe et al., 1999; Geiger and Bershadsky, 
2001). Therefore, we tested the possibility that mDia1 might be 
the Rho effector required for LPA-stimulated matrix  contraction. 
This was accomplished by knocking down mDia1expression.
Fig. 9 A shows that levels of mDia1 in mDia1-specifi  c 
siRNA, but not in mock-transfected cells, were reduced by 
>95%. mDia1-silenced cells were able to spread on collagen-
coated coverslips and form vinculin-containing focal adhesions, 
although the cells were rounder and had reduced actin stress 
fi  bers compared with controls (unpublished data), as has been 
reported (Watanabe and Higashida, 2004). Fig. 9 B shows the 
Figure 6.  PI3 kinase and Rho kinase are required for PDGF-stimulated, 
but not LPA-stimulated, collagen matrix contraction. (A) Fibroblasts were 
harvested and used to prepare ﬂ  oating collagen matrices. Samples were 
incubated for 4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF, 10 μM 
LPA, 20 μM LY294002 (LY; PI3 kinase inhibitor), and 10 μM Y27634 
(Y; Rho kinase inhibitor) added where indicated. At the end the incuba-
tions, samples were ﬁ  xed and the extent of matrix contraction was mea-
sured as the decrease in matrix diameter. Data shown are arithmetic 
means ± SD for three separate experiments. (B) Selected samples from A 
were ﬁ  xed and stained with anti-tubulin antibody for microtubules (green) 
and   rhodaminephalloidin for actin (red). Enlarged view of dendritic exten-
sion tips in the boxed areas. Bar, 20 μm.
Figure 7.  Pertussis toxin inhibits LPA-stimulated, but not PDGF-stimulated, 
collagen matrix contraction. (A) Fibroblasts in monolayer culture were in-
cubated overnight with 25 ng/ml pertussis toxin. Subsequently, the cells 
were harvested and used to prepare ﬂ  oating collagen matrices. Samples 
were incubated for 4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF or 
10 μM LPA added where indicated. At the end the incubations, samples 
were ﬁ  xed and the extent of matrix contraction was measured as the de-
crease in matrix diameter. Data shown are arithmetic means ± SD for 
three separate experiments. (B) Selected samples from A were ﬁ  xed and 
stained with anti-tubulin antibody for microtubules (green) and rhodamine-
phalloidin for actin (red). (right) Enlarged view of dendritic extension tips 
in the boxed areas. Bars, 20 μm.JCB • VOLUME 172 • NUMBER 3 • 2006  428
results of collagen matrix contraction studies with mDia1-
  silenced and mock-transfected cells. Silencing mDia1 selec-
tively inhibited LPA-stimulated contraction without affecting 
PDGF-stimulated contraction. However, knocking down mDia1 
had no effect on cell ruffl  ing (unpublished data). Therefore, dif-
ferent Rho effectors cooperated with PAK1 in fi  broblast con-
traction of fl  oating collagen matrices depending on the agonist 
used to stimulate contraction, which was Rho kinase in the 
case of PDGF and mDia1 in the case of LPA.
Control experiments were also performed to confi  rm acti-
vation of mDia1 by LPA. This was accomplished by taking ad-
vantage of the observation that LPA-stimulated formation of 
stable (nocodazole-resistant) microtubules depends on mDia1 
(Cook et al., 1998; Palazzo et al., 2001). Serum-starved mDia1-
silenced and mock-transfected cells were agonist stimulated 
and tested for the development of nocodazole- resistant 
  microtubules (Gundersen et al., 1994; Cook et al., 1998). Fig. 9 C 
shows that after agonist stimulation by PDGF or LPA, a sub-
population of microtubules in mock-transfected cells became 
nocodazole resistant, but that in mDia1-silenced cells LPA was 
no longer able to stimulate formation of stable microtubules.
Discussion
Fig. 10 summarizes the results of our studies. We found that 
PDGF and LPA regulate fl  oating collagen matrix contraction 
through signaling pathways that converge on PAK1 and its 
downstream effector, cofi  lin, and that contraction depends on 
cellular ruffl  ing activity. Moreover, different Rho effectors 
were observed to cooperate with PAK1 in regulating contrac-
tion, Rho kinase in the case of PDGF and mDia1 in the case 
of LPA.
Previous work (for review see Grinnell, 2003) had demon-
strated that the physiological agonists LPA and PDGF 
stimulated fibroblast contraction of fl  oating collagen matri-
ces, but the relationship between the signaling mechanisms in-
volved had not been elucidated. These agonists have opposite 
effects on the overall movement of fi  broblast dendritic exten-
sions: retraction in response to LPA and protrusion in response 
to PDGF (Grinnell et al., 2003). Moreover, blocking Rho ki-
nase or myosin II activity was shown to inhibit PDGF- dependent, 
but not LPA-dependent, matrix contraction (Abe et al., 2003; 
Lee et al., 2003).
PAK1 is a downstream effector for both PDGF- (Bokoch 
et al., 1996; Dharmawardhane et al., 1997) and LPA-mediated 
signaling (Menard and Mattingly, 2003; Jung et al., 2004). 
Therefore, we analyzed the possible role of PAK1 in matrix 
contraction, using siRNA to silence PAK1 expression, and 
learned that knocking down PAK1 resulted in inhibition of con-
traction stimulated by either agonist.
Microinjection and expression studies had implicated PAK1 
in ruffl  ing and motility of cells on 2D surfaces  (Dharmawardhane 
et al., 1997; Sells et al., 1997, 1999, 2000).   Although PDGF and 
LPA have opposite effects on the overall movement of fi  bro-
blast dendritic extensions, both agonists were found to stimu-
late membrane ruffl  ing activity. However, ruffl  ing by cells in 
3D matrices was inhibited in PAK1-silenced cells. In addition, 
blocking PI3 kinase selectively inhibited PDGF-stimulated cell 
ruffl  ing and matrix contraction, whereas blocking Gαi selec-
tively inhibited LPA-stimulated ruffl  ing and contraction.
As previously stated, PAK1-regulation of the actin dy-
namics required for fi  broblast ruffl  ing can be controlled at the 
level of ADF/cofi  lin phosphorylation by the PAK1 effector LIM 
kinase (Arber et al., 1998; Yang et al., 1998; Bamburg, 1999; 
Edwards et al., 1999). We found that LPA and PDGF both stim-
ulated cofi   lin1 phosphorylation, and that stimulation was 
blocked in PAK1-silenced cells. Moreover, silencing cofi  lin1 
with siRNA blocked LPA- and PDGF-dependent matrix con-
traction, as well as membrane ruffl  ing. Therefore, we suggest 
that matrix contraction requires cellular ruffl  ing  activity 
  stimulated by PAK1 and cofi  lin1. Although LIM kinase is the 
likely intermediate between PAK1 and cofi  lin1, we have not 
succeeded in developing conditions using siRNA to effectively 
silence LIM kinase expression and directly test its role.
On collagen-coated coverslips, PAK1-silenced fi  broblasts 
showed markedly decreased migration, but cells spread nor-
mally and increased formation of lamellipodia after PDGF 
stimulation. That PAK1-silenced cells formed normal lamelli-
podia in 2D culture, but lacked ruffl  es in 3D matrices, suggests 
Figure 8. Coﬁ  lin1 is downstream of PAK1 in LPA and PDGF regulation of 
collagen matrix contraction. (A) PAK1-silenced and mock-transfected cells 
were harvested and used to prepare ﬂ  oating collagen matrices. Samples 
were incubated for the times shown in DME containing 5 mg/ml BSA and 
50 ng/ml PDGF or 10 μM LPA, as indicated. At the end of the incubations, 
extracts of the samples were prepared and subjected to immunoblotting 
with antibodies directed against phospho-coﬁ   lin1 and tubulin. (B) Cells 
were transfected for 36 h with 500 nM of coﬁ  lin1 siRNA or sense RNA only 
(Mock) and then cultured an additional 24 h in growth medium without 
siRNA. Extracts were prepared and subjected to SDS-PAGE and immuno-
blotted to analyze levels of coﬁ  lin1 (arrow) and tubulin. (C) Nontransfected 
(CTL), coﬁ   lin1-silenced, and mock-transfected cells were harvested and 
used to prepare ﬂ  oating collagen matrices. Samples were incubated for 
4 h in DME with 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM LPA added 
as shown. At the end of the incuba-tions, samples were ﬁ  xed and the extent 
of matrix contraction was meas-ured as the decrease in matrix diameter. 
Data shown are arithmetic means ± SD for three separate experiments.PAK1 AND COLLAGEN MATRIX CONTRACTION • RHEE AND GRINNELL 429
that lamellipodia and ruffl  es may be regulated independently; 
PAK-independent mechanisms of cell ruffl  ing and lamellipodia 
formation have been previously described (Joneson et al., 1996; 
Westwick et al., 1997). Differences in fi  broblast adhesion to 3D 
matrices versus 2D coverslips may also be important. Besides 
LIM kinase, regulation of ADF/cofi  lin and fi  broblast ruffl  ing 
can be controlled by integrin interactions and testicular protein 
kinase 1 (Toshima et al., 2001; LaLonde et al., 2005). Cells in-
teracting with 3D matrices have fewer stress fi  bers, smaller fo-
cal adhesions, and decreased activation of focal adhesion kinase 
compared with cells in 2D culture (Cukierman et al., 2002; 
Grinnell, 2003; Wozniak et al., 2004). It is possible, therefore, 
that in 3D matrices fi  broblasts become completely dependent 
on the PAK1 pathway, whereas human fi  broblasts on 2D 
  collagen-coated surfaces can regulate cell ruffl  ing and lamelli-
podia formation by multiple mechanisms.
Also noteworthy is the discovery that the dendritic exten-
sions of PAK1-silenced fi  broblasts in 3D matrices showed de-
creased expansion in response to PDGF. This decrease may 
have resulted from an increase in microtubule catastrophe in the 
absence of PAK1 (Wittmann et al., 2003, 2004) because micro-
tubules were shown to be required for formation of the fi  bro-
blast dendritic network (Grinnell et al., 2003).
Based on molecular architecture, PAKs can be categorized 
into two subgroups with three members each (Jaffer and Cher-
noff, 2002; Bokoch, 2003; Zhao and Manser, 2005). The group 
Ι PAKs, including PAK1, share a high degree of amino acid ho-
mology and infl  uence diverse cellular processes, such as cellu-
lar morphology, migration, and gene regulation. Our results 
identify PAK1 as the major isoform involved in regula-
tion of fi  broblast ruffl  ing in 3D collagen matrices and collagen 
matrix contraction, although expression of PAK2 is at least fi  ve 
times higher than PAK1 in human fi  broblast based on Western 
blotting results.
Structurally, the major differences between PAK1 and -2
are in the NH2-terminal regulatory domain in which PAK1 
has fi  ve proline-rich Src homology 3 (SH3)–binding motifs, 
compared with two SH motifs in PAK2 (Bokoch, 2003). It has 
been reported that phosphorylation of the threonine 212 residue 
in one of PAK1’s unique SH3 motifs is important for regula-
tion of neuronal growth cone dynamics (Rashid et al., 2001). 
Whether phosphorylation at this site is also important in regu-
lation of fi  broblast contraction of collagen matrices has yet to 
be determined.
Figure 9.  mDia1 cooperates with PAK1 in LPA regula-
tion  of collagen matrix contraction silencing in human 
  ﬁ  broblasts. (A) Cells were transfected for 12 h with 700 nM 
siRNA or sense RNA only (Mock) and cultured an addi-
tional 24 h in growth medium without siRNA. Extracts 
were prepared and subjected to SDS-PAGE and immuno-
blotted to analyze levels of mDia1 and actin. (B) mDia1-
silenced and mock-transfected cells were harvested and 
used to prepare ﬂ  oating collagen matrices. Samples were 
incubated for 4 h in DME with 5 mg/ml BSA and 50 ng/ml 
PDGF or 10 μM LPA added as shown. At the end of the 
incubations, samples were ﬁ  xed, and the extent of matrix 
contraction was measured as the decrease in matrix 
  diameter. Data shown are arithmetic means ± SD for 
three separate experiments. (C) At the end of the transfec-
tion period, mock- and siRNA-transfected cells were incu-
bated in serum-free medium for 36 h, followed by 4 h in 
DME with 5 mg/ml BSA and 50 ng/ml PDGF or 10 μM 
LPA added as shown. Stable microtubules were detected 
as previously described (Gundersen et al., 1994; Cook 
et al., 1998). Subsequently, the indicated samples were 
treated with 2 μM nocodazole for 2 h . After two rinses 
with microtubule-stabilizing buffer (MSB; 85 mM Pipes, 
pH 6.9, 1 mM EGTA, 1 mM MgCl2, 2 M glycerol, 1 μg/ml 
leupeptin, 1 μg/ml pepstatin A, and 1 mM 4-(2-aminoethyl)-
benzenesulfonyl ﬂ  uoride), samples were treated with 1 ml 
of MSB containing 200 μg/ml saponin for 5 min at 37°C 
to extract tubulin monomer, rinsed with MSB, and ﬁ  xed 
with methanol (−20°C) for 10 min, and then stained with 
anti-tubulin antibody. Bar, 50 μm.
Figure 10.  Signaling pathways in ﬂ  oating collagen matrix contraction. 
Model showing convergence of PDGF and LPA signaling on PAK1 and co-
ﬁ  lin1, cell rufﬂ  ing, and collagen matrix contraction. Rho kinase cooperates 
with PAK1 for PDGF-stimulated contraction, whereas mDia1 cooperates 
with PAK1 for LPA-stimulated contraction. Rho kinase also is required for 
LPA-stimulated retraction of dendritic extensions.JCB • VOLUME 172 • NUMBER 3 • 2006  430
Although Fig. 10 shows PDGF and LPA converging sepa-
rately on PAK1, Rac is likely to be immediately upstream of 
PAK1. Preliminary studies showed that dominant-negative ex-
pression of N17Rac1, but not of N17Cdc42, completely 
abolished the formation of dendritic extensions (unpublished 
data), which was a phenotype more pronounced than observed 
by knocking down PAK1. Given the potential for indirect 
effects by overexpression of dominant-negative Ras family mu-
tants (Feig, 1999), coupled with the diffi  culty of transfecting 
genes into early passage human fi  broblasts, our initial results 
cannot yet be clearly interpreted.
During collagen matrix contraction, individual collagen 
fi  brils are translocated toward the cell surface (Grinnell and 
Lamke, 1984; Yamato et al., 1995; Tamariz and Grinnell, 2002). 
Such translocation of collagen fi  brils, when it involves fi  bro-
blasts on 2D coverslips, requires a mechanism of contractile 
force generation (Meshel et al., 2005). In the case of cell migra-
tion, PAK1-dependent cell ruffl  ing is usually thought to be im-
portant for cells to reach forward (Jaffer and Chernoff, 2002; 
Bokoch, 2003), whereas the small G protein Rho has been im-
plicated in generation of contractile force required for cell 
translocation (Webb et al., 2002; Ridley et al., 2003).
This study builds on our previous fi  nding that Rho was re-
quired for fl  oating matrix contraction (Grinnell et al., 1999) to 
show that different Rho effectors are involved in contraction de-
pendent on the agonist (i.e., Rho kinase in the case of PDGF and 
mDia1 in the case of LPA). Because blocking Rho kinase or si-
lencing mDia1 using siRNA inhibited contraction selectively, 
and neither treatment blocked cell ruffl  ing, we propose that the 
Rho effectors act in parallel to and cooperatively with the PAK1 
signaling pathway and play a role in the force generation re-
quired for matrix contraction.
At this time we can only speculate as to why LPA requires 
mDia1 rather than Rho kinase for fl  oating matrix contraction. 
Certainly, LPA activates Rho kinase in these cells because 
blocking Rho kinase has been shown to inhibit retraction of 
dendritic extensions without preventing matrix contraction 
(Abe et al., 2003; Lee et al., 2003). Rho and Rho kinase have 
been implicated in myosin II–dependent force generation 
  (Etienne-Manneville and Hall, 2002; Riento and Ridley, 2003). 
The role of mDia1 in force generation is less clear, however 
(Watanabe et al., 1999; Geiger and Bershadsky, 2001). Signifi  -
cantly, mDia1 has been implicated in the stabilization of both 
microtubules (Palazzo et al., 2004) and actin fi  laments (Wata-
nabe and Higashida, 2004), and microtubule dynamics (Dog-
terom et al., 2005; Grishchuk et al., 2005) as well as microfi  lament 
depolymerization (Mogilner and Oster, 2003) have the poten-
tial to generate force independently of actomyosin.
Materials and methods
Materials
DME and trypsin/EDTA solution were obtained from Invitrogen. BSA (fatty 
acid free) and LPA were obtained from Sigma-Aldrich. Vitrogen 100 colla-
gen was obtained from Cohesion Technologies, Inc. PDGF (BB isotype) 
was obtained from Upstate Biotechnology. LY294002, pertussis toxin, and 
Y27632 were obtained from Calbiochem-Novabiochem. Total PAK- (C-
19), PAK1- (N-20), coﬁ  lin1-,  phospho-coﬁ   lin1– (mSer 3), and mDia1-
  speciﬁ  c antibodies were obtained from Santa Cruz Biotechnology, Inc. 
rhodamine-B-isothiocyanate–conjugated phalloidin, oligofectamine, and 
Opti-MEM Ι were obtained from Invitrogen.
Cell culture
Human foreskins were obtained from anonymous donors and provided 
by the University of Texas Southwestern Medical Center. Fibroblasts from 
human foreskin specimens (<10th passage) were maintained in 75-cm
2 
tissue culture ﬂ  asks (Falcon) in DME supplemented with 10% FBS. Fibro-
blasts were harvested from monolayer culture with 0.25% trypsin/EDTA 
for 4 min at 37°C, followed by 10% FBS in DME. All incubations with cells 
were performed at 37°C in a humidiﬁ  ed incubator with 5% CO2.
For experiments with collagen matrices, cells in neutralized solutions 
of 1.5 mg/ml of collagen were prewarmed to 37°C for 3–4 min, and 0.2-ml 
aliquots were placed in 24-well culture plates (Corning). Unless otherwise 
speciﬁ  ed, cell density was 2 × 10
5 cells/matrix for matrix contraction and 
immunoblotting experiments and 2 × 10
4 cells/matrix for observing cell 
morphology. Each aliquot of collagen matrix occupied an area outlined 
by a 12-mm diam circular score within a well. After polymerization for 
60 min, matrices were gently released from the underlying culture dishes 
with a spatula and allowed to ﬂ  oat in 0.5 ml of basal medium (DME con-
taining 5 ml/ml BSA). Growth factors and inhibitors were added at the 
times indicated in the ﬁ  gure legend.
For experiments with collagen-coated surfaces, harvested cells (2 × 
10
4) were incubated for the times indicated in the ﬁ  gure legend on 12-mm
2 
glass coverslips. The coverslips were coated for 20 min with 50 μg/ml col-
lagen and then rinsed with Dulbecco’s PBS (1 mM CaCl2, 0.5 mM MgCl2, 
150 mM NaCl, 3 mM KCl, 1 mM KH2PO4, and 6 mM Na2HPO4, pH 7.2). 
Subsequently, the cultures were incubated with 1 ml DME containing 5 mg/ml 
BSA and growth factors or inhibitors as indicated in the ﬁ  gure legend.
PAK1, coﬁ  lin1, and mDia1 gene silencing
To knock down PAK1, coﬁ  lin1, and mDia1 expression in human ﬁ  broblasts, 
the following primer pairs for siRNA were designed and obtained from the 
University of Texas Southwestern Medical Center siRNA core facility. PAK1 
siRNA: 5′-A  A  C  A  C  A  C  A  A  U  U  C  A  U  G  U  C  G  G  T  T  -3′ and 5′-A  A  C  C  G  A  C  A  U  G  A-
A  U  U  G  U  G  U  G  T  T  -3′. Coﬁ   lin1 siRNA: 5′-G  C  G  G  U  G  C  U  C  U  U  C  U  G  C  C  U  G  A-
U  U  -3′and 5′-U  C  A  G  G  C  A  G  A  A  G  A  G  C  A  C  C  G  C  U  U  -3′. mDia1 siRNA: 
5′-A  U  U  C  U  U  C  U  G  C  A  U  C  A  U  A  U  G  G  T  T  -3′ and 5′-C  C  A  U  A  U  G  A  U  G  C  A  G  A  A  G-
A  A  U  T  T  -3′. For annealing, 20 μM of each single-strand 21-nt RNA was 
  incubated in annealing buffer (100 mM potassium acetate, 30 mM Hepes-
KOH, pH 7.4, and 2 mM magnesium acetate) for 2 min at 95°C, followed 
by 2 h at 37°C. To accomplish high efﬁ  ciency  transfection,  ﬁ  broblast 
  cultures (60–70% conﬂ   uent) were rinsed with antibiotic-free DME and 
treated with trypsin-EDTA for 1 min to elicit cell rounding, but not detach-
ment. Subsequently, antibiotic-free 10% FBS/DME was added at a ratio of 
4:1 to quench the trypsinization. After cells were rinsed with antibiotic-free 
DME, they were incubated with Opti-MEM I containing 700 nM siRNA- 
(PAK1 and mDia1) or 500nM siRNA-(coﬁ  lin1) annealed oligonucleotides. 
After 12 (PAK1 and mDia1) or 36 h (coﬁ  lin1), the transfection medium was 
removed and replaced with 10% FBS/DME containing antibiotics for an 
additional 24 h, at which time cells were subcultured. Mock-transfected 
cells were treated with only the sense direction oligonucleotide at double 
the concentration.
Cell migration assay
To measure 2D migration, mock- and PAK1-silenced fibroblasts were 
incubated overnight on collagen-coated coverslips with DME containing 
5 mg/ml BSA and 0.1% FBS. The cell cultures were scrape wounded with 
a pipette tip and then incubated in DME containing 5 mg/ml BSA and 
50 ng/ml PDGF.
Fluorescence microscopy
For immunostaining, collagen matrix samples were ﬁ  xed for 10 min with 
3% paraformaldehyde in PBS (3 mM KCl, 1 mM KH2PO4, 150 mM NaCl, 
and 6 mM Na2HPO4, pH 7.2.) at room temperature, blocked with 2% 
BSA/1% glycine in PBS for 30 min, and permeabilized for 15 min with 
0.5% Triton X-100 in PBS. Samples were then incubated for 1 h at 37°C 
with mouse anti–β-tubulin (1:100 dilution in 1% BSA/PBS) followed by 
45 min at 37°C with FITC-conjugated goat anti–mouse IgG. For actin stain-
ing, samples were incubated with Alexa Fluor 594–conjugated phalloidin 
(1:200 dilution in 1% BSA/PBS) for 30 min at 37°C. Samples were mounted 
on glass slides with Fluoromount G. (Southern Biotechnology Associates, 
Inc.) Images were collected using a ﬂ  uorescent microscope (Eclipse 400; 
Nikon) using 10×/0.45, 20×/0.75, and 40×/0.75 inﬁ  nity  corrected 
objectives (Plan Apo; Nikon). Images were collected at room temperature 
using a camera (SenSys; Photometrics) and MetaView acquisition software PAK1 AND COLLAGEN MATRIX CONTRACTION • RHEE AND GRINNELL 431
(Universal Imaging Corp.). Subsequent image processing was performed 
using Photoshop 5.5 or 7.0 (Adobe) in accordance with the Journal of Cell 
Biology image acquisition and manipulation instructions.
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